The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
397 jobs Number of planned job losses
Announcement Date
23 January 2007
Employment effect (start)
1 February 2007
Foreseen end date
31 December 2008
Description
Pfizer France, the French subsidiary of US pharmaceutical company Pfizer Inc, announced on 23 January 2007 to the works council that 504 jobs will be cut in France between February 2007 and December 2008.
The redundancies will affect medical representatives, the company's headquarters in Paris and a research laboratory in Amboise, which is to be closed down. The decision is part of the company's plans to cut 10,000 jobs worldwide, or about 10% of its workforce, by the end of 2008. The company's works council complained in a press release that Pfizer employees are losing their jobs for the sake of profits in a sector that is no longer taking on new staff and employees have reacted angrily to the company's restructuring plan. Despite competition from generic drug manufacturers over key medications, Pfizer's results remain extremely strong, with a profit of 15 billion USD, excluding extraordinary items being recorded in 2006. Pfizer France announced on 9 May 2007 that after discussions with the trade unions it will finally cut 397 jobs in France instead of the 504 initially announced.
Sources
23 January 2007: AFP
22 January 2007: Les Echos
24 January 2007: Le Figaro
24 January 2007: AFP
Citation
Eurofound (2007), Pfizer France, Internal restructuring in France, factsheet number 64819, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/64819.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...